|
ZNF37A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.06130000010474E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.29160000156881E-08 |
| Normal-vs-Stage2 |
4.73300000003452E-06 |
| Normal-vs-Stage3 |
7.572500E-04 |
| Normal-vs-Stage4 |
1.980250E-01 |
| Stage1-vs-Stage2 |
5.116400E-01 |
| Stage1-vs-Stage3 |
8.281200E-01 |
| Stage1-vs-Stage4 |
3.674000E-01 |
| Stage2-vs-Stage3 |
4.344800E-01 |
| Stage2-vs-Stage4 |
1.996420E-01 |
| Stage3-vs-Stage4 |
4.848600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.68379999521929E-08 |
| Normal-vs-AfricanAmerican |
2.39359999998356E-06 |
| Normal-vs-Asian |
2.371500E-02 |
| Caucasian-vs-AfricanAmerican |
8.520800E-01 |
| Caucasian-vs-Asian |
7.711000E-01 |
| AfricanAmerican-vs-Asian |
6.892200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.68170000147683E-09 |
| Normal-vs-Female |
6.334300E-02 |
| Male-vs-Female |
1.039650E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.781700E-04 |
| Normal-vs-Extreme_Weight |
1.53629999832816E-08 |
| Normal-vs-Obese |
8.47290000000056E-05 |
| Normal-vs-Extreme_Obese |
3.55200000000666E-05 |
| Normal_Weight-vs-Extreme_Weight |
2.772800E-01 |
| Normal_Weight-vs-Obese |
6.692400E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.748000E-01 |
| Extreme_Weight-vs-Obese |
7.047500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.476600E-01 |
| Obese-vs-Extreme_Obese |
1.702410E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.769900E-02 |
| Normal-vs-Age(41-60Yrs) |
4.005400E-04 |
| Normal-vs-Age(61-80Yrs) |
1.06029995894374E-09 |
| Normal-vs-Age(81-100Yrs) |
8.57980000046332E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.630800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.978100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.842000E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.920300E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.690300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.152000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.10520000040637E-07 |
| Normal-VS-Type2 PRCC |
3.22129989349662E-10 |
| Normal-VS-KIRP CIMP |
6.363800E-01 |
| Normal-VS-Unclassified PRCC |
5.254100E-02 |
| Type1 PRCC-VS-Type2 PRCC |
4.109700E-02 |
| Type1 PRCC-VS-KIRP CIMP |
5.918000E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.455600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.596600E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
2.725900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.563600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.67719221528296E-12 |
| Normal-vs-N1 |
9.621800E-02 |
| Normal-vs-N2 |
8.935300E-03 |
| N0-vs-N1 |
5.815000E-03 |
| N0-vs-N2 |
7.587600E-01 |
| N1-vs-N2 |
3.194200E-01 |
|
|
